Skip to main content

Published locations for FDA urged to bring rheumatologists into gadolinium safety discussion

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA urged to bring rheumatologists into gadolinium safety discussion

User login

  • Reset your password
  • /content/fda-urged-bring-rheumatologists-gadolinium-safety-discussion
  • /internalmedicinenews/article/189524/lupus-connective-tissue-diseases/fda-urged-bring-rheumatologists
  • /rheumatologynews/article/189524/lupus-connective-tissue-diseases/fda-urged-bring-rheumatologists
  • /rheumatology/article/189524/lupus-connective-tissue-diseases/fda-urged-bring-rheumatologists
  • /internalmedicine/article/189524/lupus-connective-tissue-diseases/fda-urged-bring-rheumatologists
  • /neurology/article/189524/lupus-connective-tissue-diseases/fda-urged-bring-rheumatologists-gadolinium
  • /clinicalneurologynews/article/189524/lupus-connective-tissue-diseases/fda-urged-bring